PMG Research Partners with Devana Solutions
Business Intelligence and Advanced Metrics Tracking technology deployed across PMG clinical trial site network
Charleston, SC - PMG Research, Inc. and Devana Solutions, LLC, today announced a long-term subscription agreement for the use of Devana's advanced cloud-based technology across PMG's industry-leading network of over
The agreement allows PMG's integrated network of sites to adopt
In addition to PMG's more than 7,700 completed clinical trials, the advanced Devana Solutions technology simultaneously tracks, aggregates and allows PMG to display and report its timing and performance metrics in real-time for all trials currently running across its entire site network.
This technology advantage, coupled with best-in-class trial management capabilities, will allow PMG Research to expand its industry leading position and secure additional trials in partnership with pharmaceutical sponsors and CROs.
Amanda Wright, Senior Director of Client Services and Communications at PMG, commented: "PMG Research has always embraced technology innovation as an important way to grow our business and to fulfill the organization's mission of bringing clinical research to as many people as possible.
"
Barry Lake, CEO & Executive Chairman of Devana, added: "PMG is clearly a leader in the site operations enterprise and we are thrilled to partner with them.
"From the first conversation, they shared Devana Solutions' opinion that more and better data about site performance will mean that the most capable networks of sites, like PMG Research, will win more awards, leading to shorter cycle times for trials, lower costs and, ultimately, lower cost treatments for patients."
About PMG Research
About Devana Solutions
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025